Global News

INC Research launches Vaccine Catalyst Site Network

Thursday, July 28, 2016

INC Research Holdings, a, global phase I to IV CRO, has launched the company’s Vaccine Catalyst Site network as part of its Catalyst program introduced earlier this year to strengthen collaborations with clinical research sites worldwide, ultimately enhancing patient focus and optimizing study delivery to drive improved predictability and increased efficiency for customers. INC selected 40 high-performing clinical research sites to participate in the initial launch of its Vaccine Catalyst Site network, which was formed to respond to the rapid growth and strong pipeline of vaccine studies.

[Read More]

LabCorp to acquire Sequenom

Thursday, July 28, 2016

Laboratory Corporation of America Holdings (LabCorp), a healthcare diagnostics company, and Sequenom, a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.

[Read More]

pSivida plan to consolidate all R&D in current U.S. facility

Wednesday, July 27, 2016

pSivida, a leader in the development of sustained release drug delivery products primarily for eye diseases, is implementing a site consolidation plan in support of its product development program and plans to conduct all future research and product development in a single location. Subject to an employee consultation process required by local U.K. law, pSivida proposes to close its research facility in Malvern, U.K. and locate all research and product development activities in the company’s state-of-the-art, cGMP facility in Watertown, Massachusetts.

[Read More]

Wiley launches Wiley Spectra Lab

Tuesday, July 26, 2016

Wiley has launched Wiley Spectra Lab, a new and flexible expert spectral data system that uses empirical data and advanced software to help chemists, toxicologists, and life scientists confidently identify chemical substances. Wiley Spectra Lab provides access to these data in a convenient, secure cloud environment.

[Read More]

AbbVie, Bristol-Myers Squibb ink oncology clinical collaboration

Tuesday, July 26, 2016

AbbVie and Bristol-Myers Squibb have announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie’s investigational biomarker-specific antibody drug conjugate Rova-T (rovalpituuzumab tesirine) in combination with Bristol-Myers Squibb’s Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a treatment for relapsed extensive-stage small cell lung cancer (SCLC).

[Read More]